Status:
UNKNOWN
B Memory Cell Response to Vaccination With the 13-valent Pneumococcal Conjugate Vaccine in Asplenic Individuals
Lead Sponsor:
Aghia Sophia Children's Hospital of Athens
Conditions:
Asplenia
β-thalassemia Major
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether one dose of the 13-valent pneumococcal conjugate vaccine (PCV13) induces immunological memory in asplenic adults and whether previously administered i...
Eligibility Criteria
Inclusion
- Asplenia
- β-thalassemia major
- older than 18 years
Exclusion
- no previously recorded allergy to PCV
- no intravenous immunoglobulin (IVIG) given within the previous 6 months
- no other vaccine given within the previous 6 months
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT01846923
Start Date
October 1 2010
Last Update
May 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
'Aghia Sophia' Children's Hospital
Athens, Attica, Greece, 11527